Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life

BACKGROUND: We studied the use of teriparatide in postmenopausal women with severe osteoporosis. MATERIAL/METHODS: Two groups (A and B) of patients affected by severe osteoporosis (T-score ⩽−2.5 at bone mineral density were analyzed and 2 vertebral fractures on radiograph). Group A was treated for 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Panico, Annalisa, Lupoli, Gelsy Arianna, Marciello, Francesca, Lupoli, Roberta, Cacciapuoti, Marianna, Martinelli, Addolorata, Granieri, Luciana, Iacono, Daniela, Lupoli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539612/
https://www.ncbi.nlm.nih.gov/pubmed/21804463
http://dx.doi.org/10.12659/MSM.881905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539612/
https://www.ncbi.nlm.nih.gov/pubmed/21804463
http://dx.doi.org/10.12659/MSM.881905

Ejemplares similares